1. Diagnosis and treatment of polycythemia vera, agnogenic myeloid metaplasia, and essential thrombocythemia;Gilbert,1991
2. The role of anagrelide, hydroxyurea, and interferon-α in treating the thrombocythemia of myeloproliferative disease. A new approach for the millennium;Gilbert,1999
3. Therapeutic dilemmas. Balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD);Murphy;Thromb Haemost,1997
4. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia;Murphy,1999
5. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols;Berk,1986